| 2008 |
 |
New Book Demysitifies the World of Clincial Trials [13K
PDF]
E. Langer (April 24, 2008) |
|
Understanding India’s New Patent Laws [148K
PDF]
E. Langer, Biopharm International (April 1, 2008) |
|
Paucity of Biopharma Approvals Raises Alarm [165K
PDF]
R. Rader, Genetic Engineering News (March 15, 2008) |
|
Biologics Regulation in India [213K
PDF]
E. Langer, Biopharm International (March 1, 2008) |
|
Top 60 Chinese Biofirms Propel Industry Forward [66K
PDF]
E. Zhou, Genetic Engineering News (February 15, 2008) |
|
India’s Biogenerics Industry [124K
PDF]
E. Langer, Biopharm International (February 1, 2008) |
|
Biopharmaceuticals in India: A New Era [116K
PDF]
E. Langer, Biopharm International (January 1, 2008) |
| 2007 |
|
China as a Biopharmaceutical Powerhouse: Just a matter of time; Despite serious obstacles, development marches ahead [204K
PDF]
E. Langer, Biopharm International, (December, 2007)
|
|
Life Science and Biotechnology Education in China [228K
PDF]
E. Langer, YB Zhou, Biopharma International, p 22 (November 1, 2007) |
|
Biopharmaceutical Exports: Converting China’s pharmaceutical manufacturing capacity [276K
PDF]
E. Langer, Biopharm International, p 24 (August 2007) |
|
Next Steps Toward Globalization: China’s service sector expanding to meet the needs of its biopharmaceutical Industry [184K
PDF]
E. Langer, YB Zhou, Biopharm International, p 26 (July 2007) |
|
Are Biotechnology Meetings and Symposia Doing the Job? [116K
PDF]
E. Langer, Biopharm International, p 66 (July 2007) |
|
Downstream Production Challenges in 2007: Study Indicates Problems May Not Be Resolved Before 2011 [104K
PDF]
E. Langer, BioProcess International, Vol. 5, No. 6, pp 22-28 (June 2007) |
|
Biogenerics in China: An Evolving Industry. China’s large domestic market potential and its competence in producing biogenerics driving future direction [176K
PDF]
E. Langer Biopharm International, p 26 (June 2007) |
|
Biopharmaceutical Disposables as a Disruptive Future Technology: The potential of single-use technology in bioproduction over the next 10 years. [104K
PDF]
Eric Langer, Brandon J. Price, BioPharm International (Jun 1, 2007) |
|
Clinical Trials in China: Is China fulfilling its clinical trials promise? [160K
PDF]
F. Kermani, Contract Pharma, p 88 (May 2007) |
|
Intellectual Property Protection in China: Does it Warrant Worry? The recent rise in patent application filings reflects new confidence in the future of patent protection [168K
PDF]
E. Langer, Biopharm International, p 20 (May 2007) |
|
Vaccine Development in China; Improvements in China’s regulatory and technology scenarios are creating an optimistic outlook for its vaccine industry [228K
PDF]; Part Two [236K PDF]
YB Zhou, Biopharm International, p 30 (April 2007) |
|
Marching into a New Era: China’s transformation into an economic global superpower…in the clinical trial sector too. [32K
PDF]
F. Kermani, Good Clinical Practices Journal, p 14 (March 2007) |
|
Outsourcing is key to future pharmaceutical R&D strategy. [#K
PDF]
Biopharm International., Faiz Kermani, Eric S. Langer (Mar 1, 2007) |
|
Biopharmaceutical Outsourcing in China: A rapidly Changing Business Environment [44K
PDF]
E. Langer, European Business Review, p 120 (Spring 2007) |
|
Managing Biopharmaceutical Manufacturing Capacity in 2007
Changes in Demand and Capacity Projected Through 2011 [104K
PDF]
Eric S. Langer, BioProcess International Vol. 5, No. 3: pp 20-26 (March 2007) |
|
GEN China Biopharma Basking in its Spotlight [524K
PDF]
YB Zhou, Genetic Engineering News p 60 (March 1 2007) |
|
Biopharmaceutical Industry Trends in China-A Five-year Perspective; Now that China has opened its window to the world, its biopharmaceutical industry will see more opportunities [56K
PDF]
YB Zhou, Biopharm International, p 32 (March 2007) |
|
Biopharmaceutical Production Outsourcing Matures: Greater Percentage of Biomanufacturers Contracting Out for Flexibility [376K
PDF]
E. Langer, BioProcess International Vol. 5, No. 2: pp 32-37 (March 2007) |
|
Pharmaceutical Distribution in China; The country strives to modernize its distribution logistics as thousands of small companies compete for profits [76K
PDF]
YB Zhou, Biopharm International, p 24 (February 2007) |
|
Evaluating Disposables: Single Use Technologies in Biomanufacturing; Live Webcast February 15, 2007 [#K
PDF]
E. Langer, Panelist, Biopharm International (Feb. 15, 2007) |
|
Opportunities in Biopharmaceutical Outsourcing to China [#K
PDF]
YB Zhou, BioProcess International, p 16 (January 2007) |
|
Defining the Chinese Biopharmaceutical Market; A relatively liberal regulatory environment and huge market potential are leading to rapid industry expansion, Part One [272K
PDF] Part Two [164K PDF]
E. Langer, YB Zhou, Biopharm International, p 24 (January 2007) |
| 2006 |
|
What China Needs for Success in Biopharmaceutical Manufacturing [#K
PDF]
E. Langer, Processing Journal (November 2006) |
|
Biomanufacturing Capacity Flat in 2006: CMOs future in Good Shape [#K
PDF]
E. Langer, Contract Pharma (Nov/Dec 2006) |
|
China-grown Pharma Products [#K
PDF]
YB Zhou, Genetic Engineering News, p 1 (Nov 15, 2006) |
|
Chinese Biogenerics and Protection of IP [628K
PDF]
Large Market Potential and Solid Foundation Sets the Stage — Eliza Yibing Zhou, BioPlan Associates, Genetic Engineering News (September 2006) |
|
Contract Research Drives China's Pharma Sector [33K
PDF]
Contract research is both a vehicle for Chinese pharmas to expand their R&D expertise and quality levels,
and a bridge for them to enter global markets. — Yibing Zhou, BioPlan Associates, PharmaManufacturing.com (August 2006) |
|
Biopharmaceutical
Approvals Review [49K
PDF]
While 2005 was a Record-Setting Year, 2006 Experiences a Slowdown — Ronald
A. Rader, BioPlan Associates, Genetic Engineering News (August 2006) |
|
Biopharma CMOs in China: Will Excess Capacity Drive the Industry? [96K
PDF]
Contract Pharma, p 110 (June 2006) |
|
CMOs and the Outsourcing Dilemma [96K
PDF]
E. Langer, World Pharmaceutical Frontiers, p 55 (Summer 2006) |
|
Purification Woes Upstage Upstream Gains [#K
PDF]
J. Ranck, Genetic Engineering News, p 46 (March 2006) |
|
Capacity Bottleneck Squeezed by Downstream Processes [#K
PDF]
E. Langer, J. Ranck, Biopharm International (March 2006) |
| 2005 |
|
Bioprocessing: Survey Assesses Biopharmaceutical Manufacturing Capacity Growth [484K PDF]
—Genetic Engineering News (November 2005) |
|
Pharmaceutical Manufacturing [196K PDF]
Biopharma Capacity on the Rise — Paul Thomas, Managing Editor, Pharmaceutical
Manufacturing (November 2005) |
|
Disposables Economics: The ROI Case — Economic Justification for Disposables in Biopharmaceutical Manufacturing [223K PDF]
BioProcess International (October 2005)
Subscribe to BioProcess International |
| 2004 |
|
Capacity Utilization in 2008 [132K PDF]
BioProcessing International (February 2004) |
|
International Competitiveness of Biopharmaceutical Manufacturing Hit by Technical Staffing Shortages [175K PDF]
Contract Pharma (February 2004) |
|
Outsourcing Biopharmaceutical Manufacturing [227K PDF]
Genetic Engineering News (January 2004) |
| 2003 and earlier |
|
Manufacturers Must Cooperate to Compete: The Biomanufacturing Industry Faces a Catch-22 [106K PDF]
Contract Pharma (October, 2002) |
|
Uniting Business and Science [74K PDF]
By Karen Nitkin for The Baltimore Sun (February 25, 2001) |
|
New Program!
Managing Technical People™ [146K PDF] |
|
New Program!
Marketing Technical Products™ [126K PDF] |
